Claire Skentelbery, Director General, EuropaBio

Updated: Apr 27

Season 2: bonus episode

In this bonus episode, GOLD is delighted to bring you the full feature-length interview with Claire Skentelbery, Director General, EuropaBio.

Claire explores the contribution that biotech will have on Europe’s future and economic footprint, the preparedness of Europe to deliver biotech’s innovative therapies at scale, as well as the investment landscape for biotech-related SMEs.


A little more on GOLD’s guest…


Claire Skentelbery was appointed Director General (DG) of EuropaBio in 2020. She holds a PhD in biochemistry and has worked in the development of scientific networks and associations for over 15 years. She started her career as part of the Cambridge biotech cluster in the UK within the cluster business network and was a founder of the Council of European BioRegions, a network of biotech clusters across Europe. She brought herself and CEBR to Brussels in 2009 where she also took on the role of SG for the European Biotechnology Network, working across sectors, organisations and countries as part of the EBN mission to facilitate partnerships. In January 2017, Claire took up her role as DG of the Nanotechnology Industries Association which she successfully led until recently.

Additional resources


If you’re interested in learning more about biotech, check out the following content:

Click here to subscribe to the weekly newsletter for more insights from GOLD.